PortfoliosLab logo
PJP vs. XPH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between PJP and XPH is 0.66, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

PJP vs. XPH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Invesco Dynamic Pharmaceuticals ETF (PJP) and SPDR S&P Pharmaceuticals ETF (XPH). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

PJP:

0.21

XPH:

0.15

Sortino Ratio

PJP:

0.28

XPH:

0.32

Omega Ratio

PJP:

1.04

XPH:

1.04

Calmar Ratio

PJP:

0.13

XPH:

0.08

Martin Ratio

PJP:

0.37

XPH:

0.32

Ulcer Index

PJP:

5.67%

XPH:

8.68%

Daily Std Dev

PJP:

17.47%

XPH:

21.57%

Max Drawdown

PJP:

-37.06%

XPH:

-48.03%

Current Drawdown

PJP:

-10.27%

XPH:

-28.73%

Returns By Period

In the year-to-date period, PJP achieves a -2.94% return, which is significantly higher than XPH's -4.97% return. Over the past 10 years, PJP has outperformed XPH with an annualized return of 1.62%, while XPH has yielded a comparatively lower -2.63% annualized return.


PJP

YTD

-2.94%

1M

-1.75%

6M

-7.98%

1Y

3.65%

3Y*

2.33%

5Y*

5.29%

10Y*

1.62%

XPH

YTD

-4.97%

1M

-0.92%

6M

-11.41%

1Y

3.27%

3Y*

0.15%

5Y*

0.04%

10Y*

-2.63%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


SPDR S&P Pharmaceuticals ETF

PJP vs. XPH - Expense Ratio Comparison

PJP has a 0.58% expense ratio, which is higher than XPH's 0.35% expense ratio.


Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

PJP vs. XPH — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PJP
The Risk-Adjusted Performance Rank of PJP is 2121
Overall Rank
The Sharpe Ratio Rank of PJP is 2525
Sharpe Ratio Rank
The Sortino Ratio Rank of PJP is 1919
Sortino Ratio Rank
The Omega Ratio Rank of PJP is 1919
Omega Ratio Rank
The Calmar Ratio Rank of PJP is 2222
Calmar Ratio Rank
The Martin Ratio Rank of PJP is 2121
Martin Ratio Rank

XPH
The Risk-Adjusted Performance Rank of XPH is 2020
Overall Rank
The Sharpe Ratio Rank of XPH is 2222
Sharpe Ratio Rank
The Sortino Ratio Rank of XPH is 2020
Sortino Ratio Rank
The Omega Ratio Rank of XPH is 2020
Omega Ratio Rank
The Calmar Ratio Rank of XPH is 1919
Calmar Ratio Rank
The Martin Ratio Rank of XPH is 2020
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

PJP vs. XPH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Pharmaceuticals ETF (PJP) and SPDR S&P Pharmaceuticals ETF (XPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current PJP Sharpe Ratio is 0.21, which is higher than the XPH Sharpe Ratio of 0.15. The chart below compares the historical Sharpe Ratios of PJP and XPH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

PJP vs. XPH - Dividend Comparison

PJP's dividend yield for the trailing twelve months is around 1.13%, less than XPH's 1.62% yield.


TTM20242023202220212020201920182017201620152014
PJP
Invesco Dynamic Pharmaceuticals ETF
1.13%0.97%1.01%0.95%0.81%0.76%0.77%1.11%0.65%0.91%5.49%2.96%
XPH
SPDR S&P Pharmaceuticals ETF
1.62%1.58%1.28%1.64%0.95%0.47%0.64%0.65%0.67%0.63%7.15%5.55%

Drawdowns

PJP vs. XPH - Drawdown Comparison

The maximum PJP drawdown since its inception was -37.06%, smaller than the maximum XPH drawdown of -48.03%. Use the drawdown chart below to compare losses from any high point for PJP and XPH.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

PJP vs. XPH - Volatility Comparison

The current volatility for Invesco Dynamic Pharmaceuticals ETF (PJP) is 6.69%, while SPDR S&P Pharmaceuticals ETF (XPH) has a volatility of 7.61%. This indicates that PJP experiences smaller price fluctuations and is considered to be less risky than XPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...